JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (BKK:JSP)
Thailand · Delayed Price · Currency is THB 1.740
-0.010 (-0.57%)
Sep 3, 2026, 12:21 PM ICT
BKK:JSP Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 957.03 | 1,010 | 824.49 | 575.58 | 458.07 | 422.34 |
Other Revenue | 35.05 | 32.46 | 21.45 | 18.78 | 8.73 | 6.78 |
| 992.08 | 1,043 | 845.93 | 594.36 | 466.8 | 429.13 | |
Revenue Growth | 0.79% | 23.26% | 42.33% | 27.32% | 8.78% | -7.27% |
Cost of Revenue | 589.72 | 604.68 | 519.49 | 432.06 | 313.11 | 277.97 |
Gross Profit | 402.35 | 438.01 | 326.44 | 162.3 | 153.69 | 151.15 |
Selling, General & Admin | 314.95 | 323.28 | 221.41 | 163.37 | 154.6 | 102.86 |
Operating Expenses | 321.6 | 328.33 | 224.09 | 162.71 | 154.77 | 102.86 |
Operating Income | 80.76 | 109.68 | 102.35 | -0.41 | -1.07 | 48.3 |
Interest Expense | -16.89 | -14.56 | -16.57 | -13 | -9.19 | -10.4 |
Earnings From Equity Investments | -0.2 | -3.3 | -3.1 | 0.58 | - | - |
Other Non Operating Income (Expenses) | - | - | - | - | - | -0.47 |
EBT Excluding Unusual Items | 63.66 | 91.83 | 82.69 | -12.83 | -10.26 | 37.43 |
Gain (Loss) on Sale of Investments | -17.66 | -17.66 | -115.99 | 39.91 | 8.89 | - |
Asset Writedown | 25.41 | 25.84 | - | 9.4 | - | - |
Other Unusual Items | - | - | - | -31.04 | -14.42 | - |
Pretax Income | 71.42 | 100 | -33.3 | 5.44 | -15.79 | 37.43 |
Income Tax Expense | 46.68 | 54.84 | -0.13 | 9.1 | 1.7 | 7.74 |
Earnings From Continuing Operations | 24.73 | 45.16 | -33.17 | -3.66 | -17.48 | 29.69 |
Minority Interest in Earnings | 18.19 | 22.7 | 37.7 | 1.94 | 0 | - |
Net Income | 42.92 | 67.87 | 4.52 | -1.72 | -17.48 | 29.69 |
Net Income to Common | 42.92 | 67.87 | 4.52 | -1.72 | -17.48 | 29.69 |
Net Income Growth | 50.98% | 1399.98% | - | - | - | -4.48% |
Shares Outstanding (Basic) | 519 | 475 | 475 | 469 | 455 | 360 |
Shares Outstanding (Diluted) | 519 | 475 | 475 | 469 | 480 | 360 |
Shares Change | 12.81% | 0.00% | 1.16% | -2.35% | 33.27% | 7.51% |
EPS (Basic) | 0.08 | 0.14 | 0.01 | -0.00 | -0.04 | 0.08 |
EPS (Diluted) | 0.08 | 0.14 | 0.01 | -0.00 | -0.04 | 0.08 |
EPS Growth | 29.38% | 1368.43% | - | - | - | -13.70% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -160.2 | -148.33 | 75.69 | -132.55 | -285.89 | 15.17 |
Free Cash Flow Per Share | -0.31 | -0.31 | 0.16 | -0.28 | -0.59 | 0.04 |
Dividend Per Share | 0.069 | 0.100 | 0.032 | - | - | 0.013 |
Dividend Growth | 30.42% | 216.46% | - | - | - | - |
Gross Margin | 40.56% | 42.01% | 38.59% | 27.31% | 32.92% | 35.22% |
Operating Margin | 8.14% | 10.52% | 12.10% | -0.07% | -0.23% | 11.25% |
Profit Margin | 4.33% | 6.51% | 0.53% | -0.29% | -3.74% | 6.92% |
Free Cash Flow Margin | -16.15% | -14.23% | 8.95% | -22.30% | -61.25% | 3.54% |
EBITDA | 130.09 | 160.43 | 147.38 | 34.1 | 16.25 | 62.89 |
EBITDA Margin | 13.11% | 15.39% | 17.42% | 5.74% | 3.48% | 14.66% |
D&A For EBITDA | 49.33 | 50.75 | 45.03 | 34.51 | 17.33 | 14.59 |
EBIT | 80.76 | 109.68 | 102.35 | -0.41 | -1.07 | 48.3 |
EBIT Margin | 8.14% | 10.52% | 12.10% | -0.07% | -0.23% | 11.25% |
Effective Tax Rate | 65.36% | 54.84% | - | 167.14% | - | 20.68% |
Revenue as Reported | 992.08 | 1,043 | 845.93 | 594.36 | 466.8 | 429.13 |
Advertising Expenses | - | 106.4 | 43.02 | 7.26 | 22.62 | 17.52 |